HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,009-1,020 of 1,979
Drug study icon
Active Not RecruitingNCT07217860

An Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

What is this study about?

Researchers are studying Azetukalner, tracking side effects to assess long-term safety and tolerability in people with bipolarity type I or II during a depressive episode.

This study is no longer accepting new participants.

Multiple locations, including Little Rock
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States
Sponsor
Xenon Pharmaceuticals Inc.
Drug study icon
CompletedNCT00309686

Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, for Bipolarity

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood Stabilizers in the Treatment of Acute Manic and Mixed Episodes Associated With Bipolar I Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed
Bipolarity, SchizophreniaMedication studyAges 18–65
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00762268

A study of SAMe for Treatment-Resistant Depression in bipolarity

What is this study about?

Researchers compared SAMe and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

In Belmont
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT05658510

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolarity (SERENITY III)

Official study title

Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Bellflower
Bipolarity, SchizophreniaMedication studyAges 18–75
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Drug study icon
TerminatedNCT00805493

Study of Riluzole in Pediatric Bipolarity

Official study title

Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder

This study ended early.

In Bethesda
Bipolarity, Depression, ...Medication studyAges 9–17
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.